Patents by Inventor Kyoko Miura

Kyoko Miura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200293570
    Abstract: An information processing method implemented by a computer, the information processing method includes: acquiring an image group generated by imaging a data group according to each of a plurality of imaging methods; for each of the acquired image groups, calculating a score of the imaging method used to generate the image group, based on distribution of a first feature value group in a feature value space, and distribution of a second feature value group in the feature value space, the first feature value group being a plurality of feature values output when the image group is input to a trained model outputting feature values corresponding to input images, the second feature value group being a plurality of feature values output when a reference image group is input to the trained model; and outputting the score of the imaging method, the score being calculated for each of the image groups.
    Type: Application
    Filed: March 6, 2020
    Publication date: September 17, 2020
    Applicant: FUJITSU LIMITED
    Inventors: TAKASHI MIURA, Yusuke Hida, Atsuo HARA, Kyoko Tadaki
  • Publication number: 20190183827
    Abstract: Compositions which contain one or more kinds of essential amino acids other than leucine and not less than 35 mol % of leucine, relative to the total content of essential amino acids, are useful for improving muscular endurance, can be ingested safely, and can efficiently improve muscular endurance conveniently in a short period of time.
    Type: Application
    Filed: February 22, 2019
    Publication date: June 20, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Kyoko MIURA, Katsuya SUZUKI
  • Patent number: 9005975
    Abstract: To efficiently identify and select a clone from clones of induced pluripotent stem cells (iPS cell) having low tumor formation rate in vivo when allowed to differentiate and transplanted in a living body, iPS cells of the clones are induced to differentiate, undifferentiated cells among the cells after the induction of differentiation are detected, and a clone having the content of the undifferentiated cell below a control is selected.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: April 14, 2015
    Assignee: Kyoto University
    Inventors: Hideyuki Okano, Yohei Okada, Shinya Yamanaka, Kyoko Miura
  • Publication number: 20120129172
    Abstract: To efficiently identify and select a clone from clones of induced pluripotent stem cells (iPS cell) having low tumor formation rate in vivo when allowed to differentiate and transplanted in a living body, iPS cells of the clones are induced to differentiate, undifferentiated cells among the cells after the induction of differentiation are detected, and a clone having the content of the undifferentiated cell below a control is selected.
    Type: Application
    Filed: May 28, 2010
    Publication date: May 24, 2012
    Applicant: KYOTO UNIVERSITY
    Inventors: Hideyuki Okano, Yohei Okada, Shinya Yamanaka, Kyoko Miura
  • Patent number: 8084064
    Abstract: The present invention provides an antiwrinkle agent and skin cosmetic composition having excellent alleviating effects on wrinkles appearing due to aging, and especially at exposed locations of skin, and a high degree of safety. The present invention relates to an antiwrinkle agent and skin cosmetic composition comprising a sclareol derivative represented by the following structural formula (1).
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: December 27, 2011
    Assignee: Kao Corporation
    Inventors: Kyoko Miura, Akinori Haratake, Syunsuke Yamazaki, Bunichi Okabe, Takeshi Ikemoto
  • Publication number: 20110183350
    Abstract: In order to provide a therapeutic agent for nerve injury which contains iPS-derived neural stem cells and has low or no risk of side effects, as well as a method for treating a nerve injury using the iPS cells, by efficiently establishing in vivo the iPS-derived neural stem having low or no risk of tumor formation, neurospheres are formed following formation of embryoid bodies from the iPS cells, and a clone whose ratio of cells in which the promoter of Nanog gene is activated is 0.01% or less is selected, and the clone is administered to a patient suffering from the nerve injury.
    Type: Application
    Filed: August 5, 2009
    Publication date: July 28, 2011
    Inventors: Hideyuki Okano, Osahiko Tsuji, Masaya Nakamura, Shinya Yamanaka, Kyoko Miura
  • Patent number: 7964638
    Abstract: The present invention is to provide skin cosmetics and anti-wrinkle agents which are excellent in reducing effect on wrinkle caused by photoaging. Skin cosmetics and anti-wrinkle agents which comprise isosorbide represented by the following formula (1).
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: June 21, 2011
    Assignee: Kao Corporation
    Inventors: Kyoko Miura, Akinori Haratake
  • Patent number: 7956087
    Abstract: The present invention is to provide skin cosmetics and anti-wrinkle agents which are excellent in reducing effect on wrinkle caused by photoaging. Skin cosmetics and anti-wrinkle agents which comprise a sugar alcohol derivative represented by the following formula (1): (wherein n is 1 to 5, preferably n=2.).
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: June 7, 2011
    Assignee: Kao Corporation
    Inventors: Kyoko Miura, Akinori Haratake
  • Publication number: 20110124586
    Abstract: Provided are an external preparation for skin and a wrinkle-reducing agent exhibiting an excellent effect of reducing wrinkles that develop particularly in an exposed site along with aging, and having high safety. The external preparation for skin and the wrinkle-reducing agent each contain an alkyl thioglycoside represented by the general formula (1): G-SR1 (1) (in the formula: G represents a sugar; R1 represents an alkyl group having 10 to 18 carbon atoms; and G and an SR1 group are bonded to each other via a ?-glycosidic bond).
    Type: Application
    Filed: July 24, 2009
    Publication date: May 26, 2011
    Applicant: Kao Corporation
    Inventors: Kyoko Miura, Akinori Haratake
  • Publication number: 20100173989
    Abstract: The present invention provides an antiwrinkle agent and skin cosmetic composition having excellent alleviating effects on wrinkles appearing due to aging, and especially at exposed locations of skin, and a high degree of safety. The present invention relates to an antiwrinkle agent and skin cosmetic composition comprising a sclareol derivative represented by the following structural formula (1).
    Type: Application
    Filed: July 9, 2009
    Publication date: July 8, 2010
    Inventors: Kyoko MIURA, Akinori Haratake, Syunsuke Yamazaki, Bunichi Okabe, Takeshi Ikemoto
  • Patent number: 7611737
    Abstract: The present invention provides an antiwrinkle agent and skin cosmetic composition having excellent alleviating effects on wrinkles appearing due to aging, and especially at exposed locations of skin, and a high degree of safety. The present invention relates to an antiwrinkle agent and skin cosmetic composition comprising a sclareol derivative represented by the following structural formula (1).
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: November 3, 2009
    Assignee: KAO Corporation
    Inventors: Kyoko Miura, Akinori Haratake, Syunsuke Yamazaki, Bunichi Okabe, Takeshi Ikemoto
  • Publication number: 20090247636
    Abstract: The present invention aims to provide a more effective gastric emptying suppressant and food intake suppressant, wherein the solving means are a gastric emptying suppressant containing 4-hydroxyisoleucine or a salt thereof and a food intake suppressant containing 4-hydroxyisoleucine or a salt thereof.
    Type: Application
    Filed: April 13, 2009
    Publication date: October 1, 2009
    Applicant: AJINOMOTO CO., INC.,
    Inventors: Atsushi KONISHI, Ikumi Ishibashi, Yoshiro Kitahara, Kyoko Miura, Sachiko Narasaka
  • Publication number: 20090208465
    Abstract: The present invention provides a therapeutic agent for a nerve injury and a method for treating a nerve injury. One aspect of the invention is the method for treating a nerve injury by administering to a patient with a nerve injury a therapeutic agent for a nerve injury containing a differentiated cell-derived pluripotent cell obtained by forced expression of reprogramming genes such as a combination of the Oct3/4 gene, Sox2 gene, Klf4, and c-myc gene. in a differentiated cell; or cells obtained by inducing the aforementioned differentiated cell-derived pluripotent cells to differentiate into an embryoid body or a neurosphere.
    Type: Application
    Filed: June 30, 2008
    Publication date: August 20, 2009
    Applicants: Keio University, Kyoto University
    Inventors: Hideyuki Okano, Masaya Nakamura, Osahiko Tsuji, Shinya Yamanaka, Kyoko Miura
  • Publication number: 20090069416
    Abstract: The present invention is to provide skin cosmetics and anti-wrinkle agents which are excellent in reducing effect on wrinkle caused by photoaging. Skin cosmetics and anti-wrinkle agents which comprise a sugar alcohol derivative represented by the following formula (1): (wherein n is 1 to 5, preferably n=2.).
    Type: Application
    Filed: January 21, 2006
    Publication date: March 12, 2009
    Inventors: Kyoko Miura, Akinori Haratake
  • Publication number: 20080293673
    Abstract: The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R1 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R2, R3, and R4 are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be ? or ?; provided that R1, R2, R3, and R4 must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.
    Type: Application
    Filed: April 23, 2008
    Publication date: November 27, 2008
    Inventors: Kyoko MIURA, Tetsuya Sayo, Shingo Sakai, Shintaro Inoue
  • Publication number: 20080293807
    Abstract: It is intended to provide a skin cosmetic and a wrinkle-reducing agent which are excellent in improving wrinkles caused by photoaging. Namely, a skin cosmetic and a wrinkle-reducing agent containing isosorbide which is represented by the following structural formula (1).
    Type: Application
    Filed: April 21, 2006
    Publication date: November 27, 2008
    Inventors: Kyoko Miura, Akinori Haratake
  • Publication number: 20080269168
    Abstract: An antiwrinkle agent which is highly effective in alleviating wrinkles caused by the photoaging. The present invention relates to an antiwrinkle agent comprising an N-acetylglucosamine organic acid ester represented by the following general formula (1): wherein R is a linear or branched acyl group having 2 to 18 carbon atoms and the configuration in the 1-position may be either ?-form or ?-form.
    Type: Application
    Filed: July 8, 2008
    Publication date: October 30, 2008
    Inventors: KYOKO MIURA, AKINORI HARATAKE, SHINGO SAKAI
  • Patent number: 7393937
    Abstract: The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R1 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R2, R3, and R4 are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be ? or ?; provided that R1, R2, R3, and R4 must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: July 1, 2008
    Assignee: Kao Corporation
    Inventors: Kyoko Miura, Tetsuya Sayo, Shingo Sakai, Shintaro Inoue
  • Publication number: 20070275999
    Abstract: The present invention provides a pharmaceutical composition containing a hypoglycemic agent(s) as an active ingredient for improving or treating impaired glucose tolerance, borderline diabetes, insulin resistance or hyperinsulinemia. The present invention further provides a pharmaceutical composition for preventing or delaying the progression from impaired glucose tolerance, borderline diabetes, insulin resistance or hyperinsulinemia to diabetes mellitus or metabolic syndromes; or the progression to the state easy to develop macrovascular disorders, cardiovascular events or ischemic heart disease.
    Type: Application
    Filed: July 31, 2007
    Publication date: November 29, 2007
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yoshiro Kitahara, Kyoko Miura
  • Publication number: 20070231416
    Abstract: The present invention provides an antiwrinkle agent and skin cosmetic composition having excellent alleviating effects on wrinkles appearing due to aging, and especially at exposed locations of skin, and a high degree of safety. The present invention relates to an antiwrinkle agent and skin cosmetic composition comprising a sclareol derivative represented by the following structural formula (1).
    Type: Application
    Filed: April 28, 2005
    Publication date: October 4, 2007
    Inventors: Kyoko Miura, Akinori Haratake, Syunsuke Yamazaki, Bunichi Okabe, Takeshi Ikemoto